Research Intelligence for R&D Teams
Atlas helps R&D teams evaluate therapeutic targets, emerging modalities, competitive pipelines, and scientific evidence with structured, publication-ready intelligence reports.
The problem
R&D teams are expected to answer questions like these every week. Yet the answers are scattered across publications, patents, conference abstracts, clinical trials, company disclosures, and regulatory filings. Atlas brings those sources together into structured intelligence reports that support research strategy, not just literature collection.
What Atlas does
Four report types, one structured pipeline, grounded in scientific and commercial evidence.
TYPE 01
Map disease biology, therapeutic modalities, clinical activity, emerging science, and commercial development.
TYPE 02
Benchmark competitors across pipelines, publications, partnerships, licensing activity, and clinical progress.
TYPE 03
Evaluate external companies, platform technologies, partnerships, and scientific positioning.
TYPE 04
Structured evidence synthesis using rigorous search methodology and publication-ready citations.
How it works
You stay in control at every checkpoint. Atlas pauses for your sign-off before research begins, before writing starts, and before delivery.
RESEARCH REFRESH
Refresh any report on a recurring schedule that fits your needs and budget, so your research keeps pace as technologies and markets evolve. Rather than running the same report again every quarter, Atlas searches for what's appeared since your last update and checks it against your existing research for meaningful changes.
Only new or updated information is added, appended to your existing report as a dated, versioned entry so you can easily track what changed over time.
Scientific rigor
Atlas is not a black box. Every stage has a structured checkpoint where you review what the system has done, edit if needed, and explicitly sign off before the next phase begins.
Use cases
Evaluate biological rationale, competitive activity, and translational evidence before investing.
Understand where a disease area is evolving and where opportunities remain.
Compare emerging scientific approaches, including efficacy, maturity, and commercial activity.
Track competitor assets from preclinical through late-stage development.
Rapidly assess external technologies, licensing opportunities, and partnerships.
Transform hundreds of publications into a structured evidence review.
Why R&D teams choose Atlas
Publications alone don't tell the whole story. Atlas connects scientific evidence with companies, funding, partnerships, and competitive activity.
Every report follows the same transparent research process, from scope to delivery.
Review checkpoints before research, writing, and delivery keep you in control throughout.
Reports executives, project teams, and governance committees can immediately use.

Knowledge repository
Connect your internal document repository and Atlas cites your materials alongside public research, automatically, at every stage of the pipeline.
Pilots available for qualified organizations.
Build on work your team has already done
Cited alongside public evidence, side by side
Ground new research in what you've already run
Prior assessments inform every new brief
Whether you're evaluating a therapeutic target, reviewing emerging science, assessing competitors, or preparing an evidence review, Atlas helps your team move from research question to decision-ready intelligence in hours.